Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis

NCT03053388 is registered in ClinicalTrials.gov with Beyond Air Inc. as lead sponsor.

NCT NCT03053388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03053388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis
Lead sponsor
Beyond Air Inc.
Phase
Phase 3
Overall status
Completed
Start date
March 5, 2017
Completion date
April 28, 2018
Enrollment
69 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiolitis